…5% CI 0.454-0.945, p=0.024), were independently associated with UDCA treatment failure (IDDF2026-ABS-0398 Figure 1).Conclusions Earl…
UDCA
This drug is selected. Its supporting articles are shown below.
Articles mentioning UDCA
28 articles · page 1 of 3…ation and highlight that further investigation into the optimal UDCA dosing strategy is warranted.Abstract IDDF2026-ABS-0146 Figure …
…us reports that UDCA acts as a gut FXR antagonist. In addition, UDCA seems to be exerting liver protective effects predominantly in …
…atment approach is a step-up model, wherein first-line therapy, ursodeoxycholic acid (UDCA), is given for a minimum of 12 months before the addition of sec…
…cribed Ursodeoxycholic acid (UDCA), Obeticholic acid (OCA), and Bezafibrate (BZA), has shown biochemical benefit in patients with inadequat…
…imit of normal (ULN), and to identify predictors of response to ursodeoxycholic acid (UDCA).Methods We conducted a single-centre retrospective study…
… was recently withdrawn from the US creating a therapeutic gap. Seladelpar (SEL), approved in 2024 in the US for patients with PBC and an …
…dentified for the 2018–2021 period; 67 patients did not receive UDCA and were excluded from the sample. A total of 1689 patients wer…
…3 F to the tumour bed. After each irradiation, a 250 mg dose of UDCA will be topically administered to the irradiated area. Radiolog…
…afibranor initiation. 2 (7.4%) patients continued OCA alongside elafibranor. 19 (70.4%) patients had trialled bezafibrate prior to elafibra…
…UDCA), obeticholic acid (OCA), and amongst those switching from bezafibrate (BZF).Results From Dec 2024 to Nov 2025, 54 pts initiated Ela (…
…binding to its promoter. Pharmacological inhibition of FXR with UDCA reversed T-cell exhaustion, and synergized with anti-PD-L1 ther…